Testing a new tool to diagnose muscle loss in older adults
Part of Brain & nervous system clinical trials.
This trial uses a high-definition surface electromyography (HD-sEMG) device to see if it can help diagnose and track sarcopenia (age-related muscle loss). It may help find better ways to monitor muscle health in people aged 75 and older.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 75 years or older.
- You have a SARC-F score of 4 or higher (a quick questionnaire about muscle weakness).
- You must have French social security coverage (not state medical aid or AME).
- You are able to give informed consent.
- Your body mass index (BMI) is under 30.
- You do not have a pacemaker, severe confusion or dementia, or a very short life expectancy (less than 3 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a high-detail sensor placed on the skin to look for signs of sarcopenia, or age-related muscle loss. The goal is to see whether the scan can help diagnose sarcopenia more accurately.
This study compares a simple calf measurement with a body scan (X-ray–based scan) to help diagnose sarcopenia, which means age-related loss of muscle strength. It may help your care team decide on the best way to recognize muscle loss early during hospitalization and follow-up.
This study is testing a new digital system to help diagnose and manage sarcopenia (age-related muscle loss). It aims to make it easier for doctors to track and treat muscle loss, which can improve your strength and quality of life.
This study looks at muscle changes in people with or at risk for sarcopenia (age-related muscle loss). It aims to find better ways to detect and manage sarcopenia using simple tests like muscle strength and body composition measurements.
This study looks for the best ways to detect sarcopenia, which means age-related loss of muscle strength and mass, in older people in a hospital or care setting. It may help doctors spot muscle problems earlier so they can plan better care.
This trial tests a new approach to treat sarcopenia (age-related muscle loss) by targeting a protein called HIF-1α. It compares older adults with sarcopenia to younger adults without it, all of whom are having hip or knee surgery.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.